Related Experiment Video
Updated: Jun 2, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 gene alterations are associated with a decreased responsiveness to neoadjuvant chemotherapy in human breast
S Lizardnacol1, B Coudert, J Riedinger
1CTR GEORGES FRANCOIS LECLERC,ONCOL SERV,F-21034 DIJON,FRANCE. CTR GEORGES FRANCOIS LECLERC,MED BIOL LAB,F-21034 DIJON,FRANCE.
Abstract:
Recent evidence indicates that alterations of the p53 tumor suppressor gene can modulate the response of tumor cells to DNA-damaging agents and increase drug resistance. To evaluate whether p53 alterations affect response to chemotherapy in breast cancer, we examined the p53 status before and after treatment of primary tumors from 44 patients who received neoadjuvant chemotherapy. p53 status was determined by gene mutations and by mRNA expression levels. Eleven patients (25%) showed alterations in the p53 gene. Comparison of the clinical response between subgroups with or without p53 alterations revealed that p53 alterations were strongly associated to clinical resistance to chemotherapy (p<0.001).
Insights
p53 gene alterations in breast cancer tumors are linked to resistance to chemotherapy. This finding suggests p53 status could predict treatment response in patients receiving neoadjuvant chemotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Alterations in the p53 tumor suppressor gene are implicated in cancer development and progression.
- The p53 gene plays a crucial role in cellular responses to DNA damage and can influence drug resistance in tumor cells.
Purpose of the Study:
- To investigate the association between p53 gene alterations and the response to neoadjuvant chemotherapy in breast cancer patients.
- To determine if p53 status (mutations and mRNA expression) can predict clinical resistance to chemotherapy.
Main Methods:
- Analysis of p53 gene status, including mutations and mRNA expression levels, in primary breast tumors.
- Examination of p53 status before and after neoadjuvant chemotherapy treatment.
- Comparison of clinical response rates between patients with and without p53 alterations.
Main Results:
- p53 gene alterations were identified in 11 out of 44 patients (25%).
- A significant association was found between p53 alterations and clinical resistance to chemotherapy (p<0.001).
Conclusions:
- p53 alterations are strongly correlated with resistance to chemotherapy in breast cancer.
- Assessing p53 status may offer a predictive biomarker for chemotherapy response in breast cancer patients.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

